The results from the TCGA microarray dataset seemed to vary slightly from the results in other datasets, and the lack of CD8+ T cells in the glioma microenvironment and the failure of immune surveillance against tumor cells were likely causes of these effects (41). The gene discussed is CD8A; the disease is neoplasm.